Shock In Court: FG Tenders Death Certificate Of Jonathan’s Ex-Aide Gulak In IPOB Case

On Wednesday, the Federal Government’s second prosecution witness, identified as BBB, presented a certified true copy (CTC) of the death certificate of Ahmed Gulak, the former Special Adviser on Political Affairs to ex-President Goodluck Jonathan.....KINDLY READ THE FULL STORY HERE▶

Gulak was allegedly murdered in 2021 by operatives of the proscribed Indigenous People of Biafra (IPOB) for reportedly violating the group’s sit-at-home directive—an incident central to the ongoing trial of IPOB leader, Nnamdi Kanu.

Appearing before Justice James Omotosho at the Federal High Court in Abuja, BBB—whose identity was concealed for safety—tendered the document while being led in evidence by the Federal Government’s counsel, Adegboyega Awomolo (SAN).

Although the hearing was scheduled for the cross-examination of the witness, Awomolo requested permission to ask a preliminary question regarding an earlier statement by the witness. Kanu’s lead counsel, Kanu Agabi (SAN), did not object, and the court granted approval.

In his query, Awomolo referred to BBB’s previous claim linking Kanu’s radio broadcast encouraging sit-at-home protests to the events that led to Gulak’s assassination. BBB confirmed this and disclosed that he had participated in the investigation that uncovered details about Gulak’s death.

BBB then submitted a police-issued certificate of death dated July 18, 2021, and a medical report outlining the circumstances of Gulak’s killing. Agabi did not contest the admissibility of the document, which Justice Omotosho formally admitted into evidence as Exhibit PWJ.

Following this, Awomolo sought the court’s approval for the witness to read the document aloud. BBB complied, reading from the certificate issued by the Nigeria Police in Owerri, Imo State, which confirmed that Ahmed Gulak was shot and killed by armed individuals allegedly linked to IPOB.

After his testimony, Kanu’s lawyer commenced the cross-examination of the witness, signaling the continuation of the high-profile trial.